Stocks
Axsome Therapeutics (AXSM) P/FCF US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| P/FCF | -26.8 | -24.8 | -31.5 | -96.8 | -121.9 | ||||
| Changes by years, y/y, % | -100% | -7% | +27% | +207% | +20.2% | ||||
Axsome Therapeutics. P/FCF
Axsome Therapeutics. P/FCF, changes, %
Axsome Therapeutics (AXSM) P/FCF US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| P/FCF | -48.1 | -42.7 | -59.9 | -98.5 | -121.9 | -121.9 | ||
| Changes by years, y/y, % | +146% | +87% | +84% | +208% | +154% | |||
| Changes by quarters, q/q, % | +50% | -11% | +40% | +64% | +24% | |||
